David J. Elliott

9.6k total citations · 1 hit paper
138 papers, 6.1k citations indexed

About

David J. Elliott is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, David J. Elliott has authored 138 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 27 papers in Genetics and 16 papers in Cancer Research. Recurrent topics in David J. Elliott's work include RNA Research and Splicing (57 papers), RNA modifications and cancer (36 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (25 papers). David J. Elliott is often cited by papers focused on RNA Research and Splicing (57 papers), RNA modifications and cancer (36 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (25 papers). David J. Elliott collaborates with scholars based in United Kingdom, United States and France. David J. Elliott's co-authors include Jennifer Munkley, Howard T. Jacobs, Caroline Dalgliesh, Ingrid Ehrmann, Prabhakar Rajan, Craig Robson, Hing Y. Leung, Andrew J. Farquharson, V. B. Math and Howard J. Cooke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

David J. Elliott

135 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions

2018 355 citations Juan L. Trincado, Juan Carlos Entizne et al. Genome biology profile →

Peers

Countries citing papers authored by David J. Elliott

Since Specialization

Citations

This map shows the geographic impact of David J. Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Elliott more than expected).

Fields of papers citing papers by David J. Elliott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Elliott. The network helps show where David J. Elliott may publish in the future.

Co-authorship network of co-authors of David J. Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Elliott. A scholar is included among the top collaborators of David J. Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Elliott. David J. Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), M. S. Murali, (unknown), Jona Merx, (unknown), Johan F. A. Pijnenborg, Thomas J. Boltje, Ning Wang, David J. Elliott, Jennifer Munkley	6
2	Differential expression of paralog RNA binding proteins establishes a dynamic splicing program required for normal cerebral cortex development 2024 ·Nucleic Acids Research ·Eleonora Cesari, Donatella Farini, (unknown), Ingrid Ehrmann, (unknown), (unknown), Chiara Naro, Maria Concetta Geloso, Vittoria Pagliarini, Livia La Barbera, Marcello D’Amelio, Tiziana Orsini, Stefano Farioli‐Vecchioli, Luca Tamagnone, Philippe Fort, Maria Teresa Viscomi, David J. Elliott, Claudio Sette	0
3	An anciently diverged family of RNA binding proteins maintain correct splicing of a class of ultra-long exons through cryptic splice site repression 2023 ·eLife ·(unknown), (unknown), (unknown), Gerald Hysenaj, Caroline Dalgliesh, Kathleen Cheung, Matthew R. Gazzara, (unknown), Katherine James, (unknown), Ingrid Ehrmann, Graham R. Smith, Simon Cockell, Jennifer Munkley, Stuart A. Wilson, Yoseph Barash, David J. Elliott	1
4	The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer 2023 ·Scientific Reports ·(unknown), (unknown), Emma Scott, (unknown), Karen E. Livermore, Huw D. Thomas, Yuhan Zhou, (unknown), Abel Bermudez, (unknown), (unknown), Gerald Hysenaj, (unknown), Rakesh Heer, Sharon J. Pitteri, Ning Wang, David J. Elliott, Jennifer Munkley	7
5	Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer 2023 ·Oncogene ·(unknown), (unknown), Emma Scott, Caroline Dalgliesh, Joachim Weischenfeldt, Jennifer Munkley, David J. Elliott	6
6	The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer 2023 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), David J. Elliott, Anna M. Eiring	4
7	De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer 2022 ·European Journal of Cancer ·Alex K. Bryant, K. Nathan Sankar, Lili Zhao, Garth W. Strohbehn, David J. Elliott, Drew Moghanaki, Michael J. Kelley, Nithya Ramnath, Michael D. Green	17
8	Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer 2021 ·Lung Cancer ·Alex K. Bryant, K. Nathan Sankar, Garth W. Strohbehn, Lili Zhao, David J. Elliott, Angel Qin, Sarah Yentz, Nithya Ramnath, Michael D. Green	22
9	SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions breakdown → 2018 ·Genome biology ·Juan L. Trincado, Juan Carlos Entizne, Gerald Hysenaj, Babita Singh, Miha Škalič, David J. Elliott, Eduardo Eyras	355
10	RNA splicing and splicing regulator changes in prostate cancer pathology 2017 ·Human Genetics ·Jennifer Munkley, Karen E. Livermore, Prabhakar Rajan, David J. Elliott	43
11	The role of glycans in the development and progression of prostate cancer 2016 ·Nature Reviews Urology ·Jennifer Munkley, Ian G. Mills, David J. Elliott	89
12	Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability 2016 ·EBioMedicine ·Jennifer Munkley, Daniel Vodák, Karen E. Livermore, Katherine James, Brian T. Wilson, Bridget Knight, Paul McCullagh, John McGrath, Malcolm Crundwell, Lorna W. Harries, Hing Y. Leung, Craig Robson, Ian G. Mills, Prabhakar Rajan, David J. Elliott	75
13	Identification of Evolutionarily Conserved Exons as Regulated Targets for the Splicing Activator Tra2β in Development 2011 ·PLoS Genetics ·Sushma Nagaraja Grellscheid, Caroline Dalgliesh, Markus Storbeck, Andrew Best, Yilei Liu, (unknown), Ylva Mende, Ingrid Ehrmann, Tomaž Curk, (unknown), Cyril F. Bourgeois, James Stévenin, D. Grellscheid, Michael S. Jackson, Brunhilde Wirth, David J. Elliott	61
14	Post-transcriptional exon shuffling events in humans can be evolutionarily conserved and abundant 2011 ·Genome Research ·Haya H. Al‐Balool, David Weber, Yilei Liu, Mark Wade, Kamlesh Guleria, (unknown), (unknown), Will Rowe, Jonathan Coxhead, Julie Irving, David J. Elliott, Andrew G. Hall, Mauro Santibanez‐Koref, Michael S. Jackson	37
15	Movement of the S4 segment in the hERG potassium channel during membrane depolarization 2009 ·Molecular Membrane Biology ·David J. Elliott, (unknown), Tim S. Munsey, Asipu Sivaprasadarao	19
16	Post-transcriptional control in the male germ line 2005 ·Reproductive BioMedicine Online ·Ingrid Ehrmann, David J. Elliott	15
17	Lack of RBM Expression as a Marker for Carcinoma In Situ of Prepubertal Dysgenetic Testis 2003 ·Journal of Andrology ·Letizia Schreiber, Beatriz Lifschitz‐Mercer, Gedalia Paz, Haim Yavetz, Zvi Zadik, Krzysztof Kula, Jolanta Słowikowska‐Hilczer, Rodolfo A. Rey, David J. Elliott, Batia Bar‐Shira Maymon	9
18	Double Immunolabeling by the RBM and the PLAP Markers for Identifying Intratubular (in Situ) Germ Cell Neoplasia of the Testis 2003 ·International Journal of Surgical Pathology ·Letizia Schreiber, Beatriz Lifschitz‐Mercer, Gedalia Paz, Haim Yavetz, David J. Elliott, Krzysztof Kula, Jolanta Słowikowska‐Hilczer, Batia Bar‐Shira Maymon	3
19	Understanding the Genes Involved in Spermatogenesis: A Progress Report 1998 ·Fertility and Sterility ·(unknown), T. B. Hargreave, David J. Elliott	42
20	The Concept of Creativity: Implications for Music Education. 1989 ·David J. Elliott	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact